Day: October 7, 2022

Decisions adopted by the Extraordinary General Meeting of Shareholders of AB Rokiškio sūris on 7 October 2022

Written by Customer Service on October 7, 2022. Posted in Public Companies.

A new member of the Board of AB Rokiškio sūris, Thomas Jan de Bruijn (Commercial & Partnership Director of Fonterra Co-operative Group Limited), was elected to the Board of AB Rokiškio sūris until the expiry of the term of office of the current Board. The term of office of the members of the Board expires on 10 December 2025. Dalius Trumpa CEO Teleph.+370 458 55200

BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base

Written by Customer Service on October 7, 2022. Posted in Public Companies.

Leading medical center in San Antonio acquires BioSig’s novel digital signal processing technology for arrhythmia care Westport, CT, Oct. 07, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced that San Antonio Methodist Hospital has acquired the PURE EP™ System. The acquisition, one of many in the pipeline, reaffirms the continued expansion of BioSig’s U.S. footprint and customer base. “As we continue to advance the national commercial rollout of the PURE EP™ System, we are thrilled to introduce our technology to Methodist Hospital in San Antonio,” said Gray Fleming, Chief Commercial Officer,...

GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders

Written by Customer Service on October 7, 2022. Posted in Public Companies.

BALTIMORE, Oct. 07, 2022 (GLOBE NEWSWIRE) — Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics today announced that it has submitted a clinical trial application to the Israel Ministry of Health for approval of a Phase 2 clinical trial for its novel neuropsychiatric cannabinoid therapy. The Company intends to conduct a Phase 2 clinical trial spearheaded by principal investigator, Dr. Adi Aran, to study the safety and efficacy of its neuroprotective cannabinoid therapeutic to treat autism related spectrum disorders (ASD) and other neuropsychiatric illnesses. The study will be conducted as a double-blind, placebo controlled trial with 100 patients ranging in age from 4-17 years old. The study is expected to begin enrolling...

Capital Southwest Announces Preliminary Estimate of Second Quarter 2023 Operating Results and Earnings Release and Conference Call Schedule

Written by Customer Service on October 7, 2022. Posted in Public Companies.

DALLAS, Oct. 07, 2022 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest,” the “Company” or “we”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, is pleased to announce its preliminary operating results for the second quarter of its 2023 fiscal year (quarter ended September 30, 2022) and its second quarter 2023 earnings release and conference call schedule. Capital Southwest’s preliminary estimate of its second quarter 2023 pre-tax net investment income is in the range of $0.52 to $0.54 per share. The preliminary estimate of its net investment income for the same period is in the range of $0.50 to $0.53 per share. Additionally, Capital Southwest’s preliminary estimate of its net...

Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices

Written by Customer Service on October 7, 2022. Posted in Mergers And Acquisitions.

Integration with the LIBERTY® Robotic System & One & Done™ Technology May Enable Future Acceleration of Robotic Adoption; Represents an Additional Growth Opportunity by Accessing the $500 Million Chronic Total Occlusion (CTO) Market1 through the Expansion of Robotic Ecosystem for Endovascular Procedures HINGHAM, Mass., Oct. 07, 2022 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced today, as a continuation of its recent regulatory and future commercialization activities, together with its strategic mission to enable accessibility to multiple endovascular procedures globally, that it has acquired the assets of privately-held Nitiloop Ltd. The acquisition includes the NovaCross™ family of Microcatheters (NovaCross CTO, NovaCross Xtreme and NovaCross BTK), a U.S. Food and Drug Administration (FDA) cleared...

Tresu Investment Holding A/S – adjustment to full year guidance

Written by Customer Service on October 7, 2022. Posted in Public Companies.

TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 10.2022 07.10.2022TRESU Investment Holding A/S – adjustment to full year 2022 guidanceTRESU Investment Holding A/S today announces an adjustment to full year guidance for 2022 mainly driven by global supply chain disruptions. The market-wide long lead times on components has caused delays in customer deliveries and project execution across all our product groups. The global supply chain disruptions have also negatively affected the gross margin on some projects from higher input prices (TRESU has not been able to push all prices through to customers on already agreed contracts) and due to lower efficiency in execution from extended component lead time. However, the underlying momentum in TRESU is strong with...

The order to supply all mineral processing technologies for ShalkiyaZinc’s greenfield zinc-lead concentrator in Kazakhstan becomes effective

Written by Customer Service on October 7, 2022. Posted in Public Companies.

COMPANY ANNOUNCEMENT NO. 16-2022 The previously announced signed contract to supply all mineral processing technology to ShalkiyaZinc, the operator of a zinc and lead mine in the Kyzylorda Region, located in the south of Kazakhstan (refer to Company Announcement No. 12-2022), is now effective. The contract is valued at around DKK 950 million and will be part of the Q4 2022 order intake. The equipment delivery is to be completed during 2024, with commissioning to start before the end of that year. The new plant will be a world-class production facility that efficiently separates the minerals with a minimised environmental impact. As detailed in the order announcement in August 2022, FLSmidth will supply two underground crushing stations with a materials handling system to the process plant, a full package of comminution and separation...

Onfolio Holdings Inc. to Acquire BWPS and SEOButler, Leading Providers of Respective WordPress Plugins and SEO Services

Written by Customer Service on October 7, 2022. Posted in Mergers And Acquisitions.

Advances Strategy of Acquiring Niche Online Businesses that Possess Strong Economics and Long-Term Growth Opportunities WILMINGTON, Del., Oct. 07, 2022 (GLOBE NEWSWIRE) — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (the “Company” or “Onfolio”), a holding company that acquires and manages a diversified portfolio of online businesses across a broad range of verticals, today announced that it has entered into two separate definitive agreements to acquire all of the assets relating to file and password protection for the WordPress sites Prevent Direct Access (PDA) and Password Protect WordPress (PPWP) (collectively “BWPS”) and to acquire all of the outstanding shares of SEOButler, Inc. (“SEOButler”). BWPS offers two main plugins that focus on file and password protection for WordPress sites, named Prevent Direct Access (PDA)...

With 8.7% CAGR, Psoriasis Treatment Market Size worth USD 47.24 billion by [2022-2029]

Written by Customer Service on October 7, 2022. Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the Psoriasis Treatment Market size is estimated to reach USD 47.25 Billion by 2029, mentions that the market stood at USD 24.33 billion in 2021 and is likely to exhibit a CAGR of 8.7% between 2022 and 2029 Pune, India, Oct. 07, 2022 (GLOBE NEWSWIRE) — The psoriasis treatment market size was USD 24.33 billion in 2021. The market is projected to grow from USD 26.37 billion in 2022 to USD 47.24 billion in 2029 at a CAGR of 8.7% during the 2022-2029 period. This vital information is presented by Fortune Business Insights™, in its report titled, “Psoriasis Treatment Market, 2022-2029.” Factors, such as rising geriatric population, increasing prevalence of plaque psoriasis, and psoriasis arthritis, will increase the footprint of the market during the forecast period. Additionally, increased focus...

Tilray Brands’ First Quarter Fiscal Year 2023 Performance Affirms Global Cannabis Leadership

Written by Customer Service on October 7, 2022. Posted in Earnings Releases And Operating Results.

Reported Net Revenue at $153.2 Million; On a Constant Currency Basis, Net Revenue Remained Strong at $166.5 Million Cannabis Gross Margin Increased to 51% from 43% in the Prior Year Quarter Delivered $108 Million in Annualized Cash Savings to Date, Expects to Deliver $130 Million Across Corporate Optimization Plans Second Highest Adjusted EBITDA in Company’s History Marking the 14th Consecutive Quarter of Positive Adjusted EBITDA Strong Balance Sheet with ~$500 Million in Cash Company Reconfirms Guidance to Generate $70-$80 Million of Adjusted EBITDA and be Free-Cash Flow Positive in Its Operating Business Units this Fiscal Year Tilray Brands Maintains #1 Cannabis Market Share in Canada and Germany LEAMINGTON, Ontario and NEW YORK, Oct. 07, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY;...

Day: October 7, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice